Edition:
India

Antares Pharma Inc (ATRS.OQ)

ATRS.OQ on NASDAQ Stock Exchange Capital Market

3.06USD
1:30am IST
Change (% chg)

$-0.02 (-0.65%)
Prev Close
$3.08
Open
$3.10
Day's High
$3.12
Day's Low
$3.02
Volume
300,651
Avg. Vol
234,561
52-wk High
$3.96
52-wk Low
$2.00

Select another date:

Mon, Oct 1 2018

Antares Pharma's testosterone drug gets FDA approval

The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected.

UPDATE 1-Antares Pharma's testosterone drug gets FDA approval

Oct 1 The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected.

Antares Pharma's testosterone drug gets FDA approval

Oct 1 The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's drug to treat low testosterone levels in men, the company said, nearly a year after rejecting the injection.

Select another date: